Stock Events

Stock Events

Alnylam Pharmaceuticals (A1LN34.SA) Q1 2017 Earnings

8FebConfirmed

Q2 2016

Q3 2016

Q4 2016

Q1 2017

-4.27

-3.96

-3.65

-3.34

Details

Expected EPS

-4.2689200000000005

Actual EPS

-4.11312

Surprise EPS

0.16

Surprise Percent

+3.65%

Description

Alnylam Pharmaceuticals (A1LN34.SA) has reported earnings of -4.11312 per share for Q1 2017.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.